Stock News

Graybill Bartz & Assoc LTD Decreased Holding in Thermo Fisher Scientific (TMO) by $710,073; Estabrook Capital Management Upped Hanesbrands Com (HBI) Holding by $47.97 Million; Share Price Declined

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Graybill Bartz & Assoc Ltd decreased its stake in Thermo Fisher Scientific Inc. (TMO) by 18.29% based on its latest 2017Q4 regulatory filing with the SEC. Graybill Bartz & Assoc Ltd sold 3,757 shares as the company’s stock rose 8.51% while stock markets declined. The institutional investor held 16,786 shares of the industrial machinery and components company at the end of 2017Q4, valued at $3.19M, down from 20,543 at the end of the previous reported quarter. Graybill Bartz & Assoc Ltd who had been investing in Thermo Fisher Scientific Inc. for a number of months, seems to be less bullish one the $84.73B market cap company. The stock decreased 0.04% or $0.08 during the last trading session, reaching $210.59. About 791,112 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 33.66% since May 17, 2017 and is uptrending. It has outperformed by 22.11% the S&P500.

Estabrook Capital Management increased its stake in Hanesbrands Inc Com (HBI) by 27.59% based on its latest 2017Q4 regulatory filing with the SEC. Estabrook Capital Management bought 2,294 shares as the company’s stock declined 7.94% with the market. The institutional investor held 10,608 shares of the clothing and shoe and accessory stores company at the end of 2017Q4, valued at $221.81M, up from 8,314 at the end of the previous reported quarter. Estabrook Capital Management who had been investing in Hanesbrands Inc Com for a number of months, seems to be bullish on the $6.49 billion market cap company. The stock increased 1.67% or $0.295 during the last trading session, reaching $17.995. About 6.13M shares traded. Hanesbrands Inc. (NYSE:HBI) has declined 8.16% since May 17, 2017 and is downtrending. It has underperformed by 19.71% the S&P500.

Among 21 analysts covering Hanesbrands (NYSE:HBI), 11 have Buy rating, 0 Sell and 10 Hold. Therefore 52% are positive. Hanesbrands had 64 analyst reports since September 17, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of HBI in report on Monday, September 25 with “Hold” rating. Barclays Capital maintained it with “Overweight” rating and $22 target in Wednesday, May 2 report. The company was maintained on Thursday, November 2 by Nomura. Citigroup maintained it with “Neutral” rating and $19 target in Wednesday, May 2 report. Wells Fargo reinitiated the stock with “Outperform” rating in Thursday, October 22 report. The stock of Hanesbrands Inc. (NYSE:HBI) has “Buy” rating given on Friday, February 3 by UBS. Deutsche Bank initiated Hanesbrands Inc. (NYSE:HBI) on Monday, October 23 with “Buy” rating. Citigroup maintained the shares of HBI in report on Thursday, August 4 with “Buy” rating. FBR Capital maintained Hanesbrands Inc. (NYSE:HBI) on Thursday, February 8 with “Buy” rating. The firm earned “Hold” rating on Thursday, February 8 by Stifel Nicolaus.

Since February 15, 2018, it had 0 insider buys, and 1 insider sale for $1.07 million activity.

Estabrook Capital Management, which manages about $1.18B and $662.80B US Long portfolio, decreased its stake in Bank Of New York Mellon Corpor (NYSE:BK) by 2,900 shares to 85,311 shares, valued at $4.59 billion in 2017Q4, according to the filing. It also reduced its holding in Mcdonalds Corp (NYSE:MCD) by 80 shares in the quarter, leaving it with 1,923 shares, and cut its stake in Aflac Inc (NYSE:AFL).

Investors sentiment decreased to 1.11 in Q4 2017. Its down 0.04, from 1.15 in 2017Q3. It worsened, as 75 investors sold HBI shares while 173 reduced holdings. 79 funds opened positions while 197 raised stakes. 337.77 million shares or 0.93% more from 334.65 million shares in 2017Q3 were reported. Arrowstreet Cap Partnership invested in 0.03% or 631,900 shares. Parallax Volatility Advisers Lp has 8,520 shares. Oak Limited Oh stated it has 0.35% in Hanesbrands Inc. (NYSE:HBI). Rothschild Invest Il accumulated 0.23% or 102,589 shares. Central Bankshares Co reported 0.01% in Hanesbrands Inc. (NYSE:HBI). Barclays Public Limited Com accumulated 0.01% or 681,755 shares. Huntington Bank & Trust has 2,292 shares. Wealthtrust Axiom Ltd Limited Liability Company has invested 1.18% of its portfolio in Hanesbrands Inc. (NYSE:HBI). Pinebridge Invs Ltd Partnership has invested 0.02% in Hanesbrands Inc. (NYSE:HBI). Braun Stacey Assoc Incorporated has invested 0.24% in Hanesbrands Inc. (NYSE:HBI). Mesirow Inv has 0.06% invested in Hanesbrands Inc. (NYSE:HBI) for 43,345 shares. Estabrook Mgmt has 10,608 shares for 0.03% of their portfolio. Ny State Common Retirement Fund reported 861,899 shares stake. Moreover, North Star Asset Mgmt Inc has 0.7% invested in Hanesbrands Inc. (NYSE:HBI). Armistice Ltd has invested 2.92% in Hanesbrands Inc. (NYSE:HBI).

More notable recent Hanesbrands Inc. (NYSE:HBI) news were published by: Seekingalpha.com which released: “Small Cap Dividend Spotlight: HanesBrands” on April 29, 2018, also Seekingalpha.com with their article: “HanesBrands: Value-Investor Opportunity” published on April 25, 2018, Seekingalpha.com published: “Why Hanesbrands Is Falling” on May 03, 2018. More interesting news about Hanesbrands Inc. (NYSE:HBI) were released by: Seekingalpha.com and their article: “Hanesbrands: Honing In On A Swing Low” published on May 15, 2018 as well as Seekingalpha.com‘s news article titled: “Hanesbrands (HBI) Q1 2018 Results – Earnings Call Transcript” with publication date: May 01, 2018.

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 63 analyst reports since July 24, 2015 according to SRatingsIntel. Jefferies maintained the shares of TMO in report on Thursday, March 30 with “Hold” rating. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Stifel Nicolaus on Monday, January 11. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Wednesday, January 3 by Evercore. Barclays Capital maintained the shares of TMO in report on Thursday, February 1 with “Overweight” rating. Cleveland upgraded the stock to “Buy” rating in Thursday, July 20 report. The rating was maintained by Jefferies with “Hold” on Wednesday, September 27. The firm has “Outperform” rating given on Monday, October 9 by Leerink Swann. On Thursday, February 1 the stock rating was maintained by Morgan Stanley with “Overweight”. As per Monday, December 4, the company rating was maintained by Leerink Swann. As per Friday, October 20, the company rating was maintained by Jefferies.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on July, 25. They expect $2.69 earnings per share, up 16.96% or $0.39 from last year’s $2.3 per share. TMO’s profit will be $1.08B for 19.57 P/E if the $2.69 EPS becomes a reality. After $2.50 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 7.60% EPS growth.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.05, from 0.96 in 2017Q3. It worsened, as 43 investors sold TMO shares while 410 reduced holdings. 93 funds opened positions while 319 raised stakes. 335.65 million shares or 0.74% more from 333.20 million shares in 2017Q3 were reported. Blb&B Advisors Ltd Liability Corp reported 1,791 shares. Schroder Investment Management Grp Incorporated holds 0.34% or 1.10 million shares. Cohen Cap Management Incorporated has 3.44% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 77,815 shares. Synovus Corporation owns 3,507 shares. Gradient Investments Ltd reported 0% in Thermo Fisher Scientific Inc. (NYSE:TMO). Smithfield Tru holds 6,725 shares. Brown Advisory Securities Limited Liability Company holds 2,154 shares or 0.08% of its portfolio. Millennium Mgmt Ltd Com stated it has 0.01% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Moreover, Banque Pictet & Cie has 1.43% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 376,499 shares. Moreover, Dekabank Deutsche Girozentrale has 0.4% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 294,699 shares. Oklahoma-based Tru Of Oklahoma has invested 1.24% in Thermo Fisher Scientific Inc. (NYSE:TMO). Dnb Asset Mngmt As stated it has 85,848 shares. Amica Pension Fund Board Of Trustees stated it has 19,269 shares or 0.42% of all its holdings. Wealth Architects Ltd invested in 1,377 shares or 0.09% of the stock. Hudson Valley Advsrs Adv holds 2.03% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 43,354 shares.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Streetinsider.com which released: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” on May 15, 2018, also Streetinsider.com with their article: “Omega’s 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More…)” published on May 15, 2018, Streetinsider.com published: “Viking Global’s 13F Shows New Stakes in Alibaba (BABA), BioMarin (BMRN) and Western Digital (WDC), Increase in …” on May 15, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: 247Wallst.com and their article: “UBS Makes Big Health Care Swap in Top Performing Q-GARP Portfolio” published on May 14, 2018 as well as Streetinsider.com‘s news article titled: “Appaloosa 13F Shows New Stake in Wells Fargo (WFC) and Lam Research (LRCX), Increase in Micron (MU) MGM …” with publication date: May 15, 2018.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *